universities news from FierceBioResearcher
News
VC firm looks to early-stage research projects
MIT computer model designs better therapies
Israeli group creating fund for drug research
The Israeli Life Sciences Industry group is helping set up a $300 million to $500 million initiative to spur the development of biotechnology and help finance drug research in the country. Chief Scientist Dr. Eli Opper says that the country is already in negotiations with multinational biotech companies to create development centers in Israel while the government is adding to the biotech/nanotech activities of Israel's universities. Care Capital partner Dr. Argeris N. Karabelas told the …
Read more...Universities, public institutes lead biotech revolution
A worldwide analysis of biotech patents shows that universities and public research institutions play the leading role in drug discovery, with the U.S. and Japan well ahead of Europe in innovation. The intellectual property firm Marks & Clerk examined patents filed between 2002 and 2006 and found that the Japan Science and Technology Agency played the lead role in filing 1,022 patent "families;" clusters of patents all linked to a single discovery. The University of California ranked …
Read more...Johns Hopkins to host cardiovascular research 'grid'
A group of three universities has banded together to create a research grid that will allow cardiovascular researchers to share data, analytical tools and models on healthy and diseased patients. The Institute for Computational Medicine at Johns Hopkins University will host the grid--which is being funded with an $8.5 million federal grant--and work with Ohio State University and the University of information that can be shared by everyone who is connected. And that's a big advance from …
Read more...Paid Research Reports
- Drug Repositioning Strategies - Serendipity by design
- eHealthInsight Series: Online Patient Recruitment Strategies - Optimizing the clinical trial process
- Pricing & Reimbursement - Seven Major Markets Update
- Innovative Clinical Trial Design and Management: Trends, success stories and impact upon R&D budgets
- The Emerging Role of Postmarketing Clinical Research: Regulatory issues, strategic drivers and overall trends

